Cargando…

Expression of G1→S Transition Regulatory Molecules in Human Urothelial Cancer

Growth of cancer cells is characterized by accelerated passage through the cell cycle, which is often caused by deregulation of the G1→S transition. In this study the expression of G1→S transition regulatory molecules was analyzed in 32 transitional cell carcinoma specimens and fifteen normal tissue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oya, Mototsugu, Schmidt, Bettina, Schmitz‐Dräger, Bernd J., Schulz, Wolfgang A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1998
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921887/ https://www.ncbi.nlm.nih.gov/pubmed/9738978 http://dx.doi.org/10.1111/j.1349-7006.1998.tb03276.x

Ejemplares similares

DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas
por: Florl, A R, et al.
Publicado: (1999)

Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2022)

Multiple Mechanisms Mediate Resistance to Sorafenib in Urothelial Cancer
por: Knievel, Judith, et al.
Publicado: (2014)

Expression level of dihydropyrimidine dehydrogenase is associated with clinical outcome in patients with T1G3 bladder cancer treated with Bacillus Calmette-Guerin
por: Ide, Hiroki, et al.
Publicado: (2014)

Role of the MUC1‐C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2020)

CDK12 and HER2 coamplification in two urothelial carcinomas with rapid and aggressive clinical progression
por: Yanai, Yoshinori, et al.
Publicado: (2020)

Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer
por: Hagiwara, Masayuki, et al.
Publicado: (2018)

Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma
por: Ide, Hiroki, et al.
Publicado: (2012)

HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal Transition
por: Jaguva Vasudevan, Ananda Ayyappan, et al.
Publicado: (2019)

IDH2 stabilizes HIF‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer
por: Shigeta, Keisuke, et al.
Publicado: (2023)

Analysis of cabazitaxel‐resistant mechanism in human castration‐resistant prostate cancer
por: Hongo, Hiroshi, et al.
Publicado: (2018)

Alterations of Chromatin Regulators in the Pathogenesis of Urinary Bladder Urothelial Carcinoma
por: Hoffmann, Michèle J., et al.
Publicado: (2021)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

Decreased expression of p57(KIP2)mRNA in human bladder cancer
por: Oya, M, et al.
Publicado: (2000)

The role of c-FLIP splice variants in urothelial tumours
por: Ewald, F, et al.
Publicado: (2011)

Proteomic and transcriptomic profiles of human urothelial cancer cells with histone deacetylase 5 overexpression
por: Jaguva Vasudevan, Ananda Ayyappan, et al.
Publicado: (2022)

CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

Oncological outcomes of dose reductions in cisplatin due to renal dysfunction for patients with metastatic urothelial carcinoma
por: Murakami, Tetsushi, et al.
Publicado: (2021)

The human leukocyte antigen G molecule (HLA-G) expression in patients with nasal polyposis()
por: Avelino, Melissa Ameloti Gomes, et al.
Publicado: (2014)

The Impact of the Receptor of Hyaluronan-Mediated Motility (RHAMM) on Human Urothelial Transitional Cell Cancer of the Bladder
por: Niedworok, Christian, et al.
Publicado: (2013)

HERV-K and LINE-1 DNA Methylation and Reexpression in Urothelial Carcinoma
por: Kreimer, Ulrike, et al.
Publicado: (2013)

Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder
por: Nomura, Shunichiro, et al.
Publicado: (2020)

Canonical Notch signalling is inactive in urothelial carcinoma
por: Greife, Annemarie, et al.
Publicado: (2014)

The role of cell adhesion molecules in the progression of bladder urothelial carcinomas
por: Săndulescu, Andrei Ştefan, et al.
Publicado: (2022)

Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma
por: Yoshimine, S, et al.
Publicado: (2013)

APOBEC3B Activity Is Prevalent in Urothelial Carcinoma Cells and Only Slightly Affected by LINE-1 Expression
por: Jaguva Vasudevan, Ananda Ayyappan, et al.
Publicado: (2018)

Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

Antioncogenic Effects of Transient Receptor Potential Vanilloid 1 in the Progression of Transitional Urothelial Cancer of Human Bladder
por: Santoni, Giorgio, et al.
Publicado: (2012)

Frequent and heterogeneous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma.
por: Clasen, S., et al.
Publicado: (1998)

Visceral to total obesity ratio and severe hydronephrosis are independently associated with prolonged pneumoperitoneum operative time in patients undergoing laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2015)

Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment
por: Lehmann, Maria, et al.
Publicado: (2014)

ZIP8 expression in human proximal tubule cells, human urothelial cells transformed by Cd(+2) and As(+3) and in specimens of normal human urothelium and urothelial cancer
por: Ajjimaporn, Amornpan, et al.
Publicado: (2012)

Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?
por: Kosaka, Takeo, et al.
Publicado: (2014)

Transient hypercalcemia in a patient with SAPHO syndrome
por: Yoshida, Tadashi, et al.
Publicado: (2021)

HLA-G as a Tolerogenic Molecule in Transplantation and Pregnancy
por: Rebmann, Vera, et al.
Publicado: (2014)

Urothelial cancer gene regulatory networks inferred from large-scale RNAseq, Bead and Oligo gene expression data
por: Matos Simoes, Ricardo de, et al.
Publicado: (2015)

Human kidney injury molecule-1 as a urine biomarker differentiating urothelial and renal cell carcinoma
por: Białek, Łukasz, et al.
Publicado: (2021)

Complete Response to Bicalutamide Withdrawal Prolonged for Almost 2 Years in Patients With Metastatic Prostate Cancer()
por: Hongo, Hiroshi, et al.
Publicado: (2014)

Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems
por: Eriksson, Pontus, et al.
Publicado: (2015)

Epigenetic Regulation of Elf5 Is Associated with Epithelial-Mesenchymal Transition in Urothelial Cancer
por: Wu, Bo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0sbi2n6st4ontb5892gqdhv2vn